NXL 8-K 2026-07-29

Nexalin Technology, Inc. (NXL) 8-K dated 2026-07-29 — accession 0001829126-26-008047. This URL is the filing, not the NXL hub.

Nexalin Technology, Inc. (NXL) is a medical devices company listed on NASDAQ.

Nexalin Technology, Inc. filed a 8-K on 2026-07-29. Accession 0001829126-26-008047.

Cached items: 1.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NXL revenue for 2025-12-31 was $301.6K. Net income was -$8.2M. Revenue was up 78.8% from 2024-12-31 to 2025-12-31. NXL currently screens at market cap $8.5M.

Not investment advice. The NXL SEC hub lists recent forms. The stock page is the research view.